NIH Clinical Research Studies

Protocol Number: 81-N-0010

Active Accrual, Protocols Recruiting New Patients

Title:
Regional Cerebral Utilization of Glucose in Patients with a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders
Number:
81-N-0010
Summary:
The Cognitive Neuroscience Section of the National Institute of Neurological Disorders and Stroke proposes to continue its cross-sectional and longitudinal studies of cerebral metabolism in frontal lobe dementias and atypical basal ganglia disorders. These studies include repeated assessments of neuropsychological and brain anatomical and metabolic function in subjects with these important and possibly related brain disorders.
Sponsoring Institute:
National Institute of Neurological Disorders and Stroke (NINDS)
Recruitment Detail
Type: Participants currently recruited/enrolled
Gender: Male & Female
Referral Letter Required: No
Population Exclusion(s): Children

Eligibility Criteria:
Subjects will be recruited from the NIH referral center, neurological and psychiatric clinics, from self or family referral in response to advertisements or from private physicians. Healthy volunteers will include subjects who are considered aT-risk for the development of FTD or CBS and subjects who serve as normal controls matched for key characteristics with the patients.

INCLUSION CRITERIA FOR PATIENTS:

-Diagnosis of possible / probable FTD or CBS

-Caregiver willing and able to accept the responsibilities involved in the study

EXCLUSION CRITERIA:

-Pregnant women. Women of childbearing potential will be screened by history for the possibility of pregnancy and undergo a urine pregnancy test. These women will be excluded from the imaging portions of the protocol.

-Behavioral symptoms that would preclude the gathering of data for the study

-Other medical or social condition that would preclude participation in the opinion of the investigators

Special Instructions:
Currently Not Provided
Keywords:
Alzheimer's Disease
Cerebral Metabolism
Cerebrospinal Fluid
Dementia of the Alzheimer Type
18-F-Fluoro-2-Deoxy-D-Glucose (FDG)
Magnetic Resonance Imaging
Positron Emission Tomography
X-Ray Computed Tomography (CT)
Senile Dementia
Recruitment Keyword(s):
Down Syndrome
Trisomy 21
Condition(s):
Alzheimer's Disease
Dementia
Down's Syndrome
Investigational Drug(s):
18 FDG
Investigational Device(s):
None
Intervention(s):
None
Supporting Site:
National Institute of Neurological Disorders and Stroke

Contact(s):
Patient Recruitment and Public Liaison Office
Building 61
10 Cloister Court
Bethesda, Maryland 20892-4754
Toll Free: 1-800-411-1222
TTY: 301-594-9774 (local),1-866-411-1010 (toll free)
Fax: 301-480-9793

Electronic Mail:prpl@mail.cc.nih.gov

Citation(s):
Computed tomographic analysis of barin morphometrics in 30 healthy men, aged 21 to 81 years

Relation of maesured brain glucose utilization and cerebral atrophy in man

Human brain glucose utilization and cognitive function in relation to age

Active Accrual, Protocols Recruiting New Patients

If you have:


Command Menu Bar

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home


Clinical Center LogoNational Institutes of Health Clinical Center Bethesda, Maryland 20892. Last update: 01/30/2009
Search The Studies Help Questions